Optimizing TruBridge (CPSI) Cosentyx Prior Authorization Workflows

Klivira streamlines the complex TruBridge (CPSI) Cosentyx prior authorization process, enabling rural and community hospitals to accelerate patient access to critical IL-17A inhibitor therapies.

For revenue cycle directors and prior authorization coordinators utilizing TruBridge (CPSI), managing specialty drug PAs like Cosentyx (secukinumab) presents unique challenges. Klivira's platform integrates directly with your existing Evident EHR environment to automate the submission and tracking of these high-volume, high-value authorizations. We focus on reducing manual burdens and improving turnaround times for critical therapies.

Navigating Cosentyx PA Within the TruBridge Ecosystem

The authorization process for Cosentyx, an IL-17A inhibitor, typically initiates within the TruBridge (Evident/Thrive EHR) order entry module. Upon prescription, the system identifies the need for prior authorization based on formulary rules. Klivira's integration ensures that this trigger seamlessly transitions into an automated ePA workflow, bypassing manual forms and faxes often associated with traditional TruBridge PA processes. This includes intelligent routing to appropriate specialty pharmacies for fulfillment.

Addressing Pharmacy vs. Medical Benefit for Specialty Biologics

IL-17A inhibitors like Cosentyx often present a critical distinction between pharmacy benefit and medical benefit coverage, depending on the payer and site of administration. Klivira's platform is engineered to identify and manage this split within the TruBridge revenue cycle context. We ensure the correct X12 278 (ePA) or NCPDP SCRIPT (ePrescribing) transaction is initiated, aligning with the specific benefit structure to prevent delays or denials related to incorrect submission pathways.

Automated Documentation Retrieval from TruBridge EHR

Effective prior authorization for Cosentyx requires comprehensive clinical documentation. Klivira leverages SMART on FHIR capabilities where available, or robust API integrations, to extract necessary data directly from TruBridge (Evident/Thrive EHR) patient charts. This includes pulling relevant ICD-10 codes from the problem list (e.g., for psoriasis, psoriatic arthritis, ankylosing spondylitis), past medication history, progress notes detailing disease activity, and laboratory results to substantiate medical necessity criteria.

Key Data Points Klivira Extracts from TruBridge for Cosentyx PAs:

  • Patient demographics and insurance information.
  • ICD-10 diagnoses from the problem list (e.g., L40.0, M07.0, M45.0).
  • Medication history, including prior biologic failures or contraindications.
  • Clinical notes detailing disease severity, PASI scores, BSA, or DAS28 scores.
  • Relevant lab results (e.g., CRP, ESR) and imaging reports.
  • Documentation of failed conventional therapies or specific treatment criteria.

Enhanced Efficiency for Rural and Community Hospitals

For rural and community hospitals relying on TruBridge, administrative burdens can disproportionately impact limited resources. Automating Cosentyx prior authorizations with Klivira frees up PA coordinators and clinical staff, allowing them to focus on patient care rather than manual paperwork. Our solution is designed to integrate seamlessly into existing TruBridge workflows, providing a significant operational uplift without requiring extensive IT overhead.

Frequently asked questions

How does Klivira integrate with TruBridge (CPSI) for Cosentyx prior authorizations?

Klivira integrates with TruBridge (Evident/Thrive EHR) via available APIs and established data exchange protocols. This allows for automated identification of PA requirements, extraction of necessary clinical documentation, and electronic submission of the authorization request for Cosentyx, streamlining the entire process from order entry to payer response.

Can Klivira handle both pharmacy and medical benefit PAs for Cosentyx?

Yes, Klivira is built to manage both pharmacy and medical benefit prior authorizations for specialty drugs like Cosentyx. Our system intelligently determines the appropriate submission pathway (e.g., X12 278 for medical benefit, NCPDP SCRIPT for pharmacy benefit) based on payer rules and patient coverage identified within the TruBridge system, ensuring accurate and efficient processing.

What is the typical impact on PA turnaround times for TruBridge users with Klivira?

While specific numbers vary by payer and complexity, Klivira's automation significantly reduces manual touchpoints and accelerates the data gathering and submission phases of Cosentyx PAs. This typically leads to faster submission, proactive issue resolution, and ultimately, a reduction in overall PA turnaround times for TruBridge (CPSI) users.

Is Klivira compliant with HIPAA regulations when accessing patient data from TruBridge?

Yes, Klivira operates with strict adherence to HIPAA regulations. Our platform employs robust security measures, encryption protocols, and access controls to ensure the protection of all ePHI accessed from TruBridge or any integrated EMR. We maintain compliance with all relevant data privacy and security standards.

Does Klivira support other IL-17A inhibitors or biologics within the TruBridge environment?

Yes, Klivira's platform is designed to support prior authorizations for a broad spectrum of specialty medications, including other IL-17A inhibitors and biologics, within the TruBridge (CPSI) ecosystem. Our system is configurable to handle the unique clinical criteria and documentation requirements for various high-cost therapies across multiple specialties.

Related coverage

Other cpsi prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo